Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins

被引：4

作者：

Gresch, Gerrit ^{[1
,2
]}

Schenke, Lea ^{[1
,2
]}

Mladenov, Radoslav ^{[1
]}

Zwirner, Stefan ^{[1
]}

Cremer, Christian ^{[2
]}

Niesen, Judith ^{[1
]}

Grieger, Elena ^{[1
,2
]}

Bruemmendorf, Tim ^{[3
]}

Jost, Edgar ^{[3
]}

Fischer, Rainer ^{[1
]}

Stockmeyer, Bernhard ^{[4
]}

Barth, Stefan ^{[1
,2
,5
]}

Nachreiner, Thomas ^{[2
]}

Stein, Christoph ^{[1
,2
]}

机构：

[1] Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept Immunotherapy, Aachen, Germany

[2] RWTH Aachen Univ Hosp, Inst Appl Med Engn, Aachen, Germany

[3] RWTH Aachen Univ Hosp, Dept Haematol & Oncol Internal Med 4, Aachen, Germany

[4] Univ Erlangen Nurnberg, Dept Internal Med 5, Haematol Oncol, Erlangen, Germany

[5] Univ Cape Town, South African Res Chair Canc Biotechnol, Inst Infect Dis & Mol Med IDM, Dept Integrat Biomed Sci,Fac Hlth Sci, Cape Town, South Africa

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 183卷 / 02期

关键词：

leukaemia; human cytolytic fusion proteins (hCFP); angiogenin (Ang); microtubule-associated protein tau (MapTau); single-chain Fragment variable (scFv); FC-ALPHA-RI; IMMUNOTOXIN RESISTANCE; CANCER; METHYLATION; GENERATION; ANGIOGENIN; RECEPTOR; PROMOTER; THERAPY;

D O I：

10.1111/bjh.14971

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：313 / 317

页数：5

共 10 条

[1] The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity
Bakema, J. E.
van Egmond, M.
[J]. MUCOSAL IMMUNOLOGY, 2011, 4 (06) : 612 - 624
[2] Angiogenin Mutants as Novel Effector Molecules For the Generation of Fusion Proteins With Increased Cytotoxic Potential
Cremer, Christian
Vierbuchen, Tim
Hein, Lea
Fischer, Rainer
Barth, Stefan
Nachreiner, Thomas
[J]. JOURNAL OF IMMUNOTHERAPY, 2015, 38 (03) : 85 - 95
[3] Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
Hristodorov, D.
Mladenov, R.
Pardo, A.
Pham, A-T
Huhn, M.
Fischer, R.
Thepen, T.
Barth, S.
[J]. BRITISH JOURNAL OF CANCER, 2013, 109 (06) : 1570 - 1578
[4] Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8
Hu, Xiaobo
Wei, Hui
Xiang, Laiman
Chertov, Oleg
Wayne, Alan S.
Bera, Tapan K.
Pastan, Ira
[J]. LEUKEMIA RESEARCH, 2013, 37 (11) : 1551 - 1556
[5] Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
Mathew, Mrudula
Verma, Rama S.
[J]. CANCER SCIENCE, 2009, 100 (08): : 1359 - 1365
[6] The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia
Mladenov, Radoslav
Hristodorov, Dmitrij
Cremer, Christian
Hein, Lea
Kreutzer, Fabian
Stroisch, Tim
Niesen, Judith
Brehm, Hannes
Blume, Tobias
Bruemmendorf, Tim Henrik
Jost, Edgar
Thepen, Theophilus
Fischer, Rainer
Stockmeyer, Bernhard
Barth, Stefan
Stein, Christoph
[J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (11) : 2729 - 2738
[7] SAXENA SK, 1992, J BIOL CHEM, V267, P21982
[8] Fc alpha RI (CD89) as a novel trigger molecule for bispecific antibody therapy
Valerius, T
Stockmeyer, B
vanSpriel, AB
Graziano, RF
vandenHerikOudijk, IE
Repp, R
Deo, YM
Lund, J
Kalden, JR
Gramatzki, M
vandeWinkel, JGJ
[J]. BLOOD, 1997, 90 (11) : 4485 - 4492
[9] Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy
Wei, Hui
Xiang, Laiman
Wayne, Alan S.
Chertov, Oleg
FitzGerald, David J.
Bera, Tapan K.
Pastan, Ira
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (18) : 6898 - 6903
[10] Weidle UH, 2014, CANCER GENOM PROTEOM, V11, P25

← 1 →